Oncology
Advertisement
Dr. Mik Rinne discusses a study on the efficacy of the CDK2 inhibitor BLU-222 in patients with HR+/HER2- breast cancer.
A factor secreted by tumor cells is responsible for the resistance of melanoma to treatment.
Dr. Anne Marie Morse discusses the link between cancer and sleep and circadian science.
Hormone therapy was associated with a 19% lower relative risk in Black women aged 65 to 74 years.
A study aimed to assess the long-term survival outcomes and disease patterns of male breast cancer patients.
Researchers developed a tool to predict nervous system side effects experienced by breast cancer patients using taxanes.
A year of treatment with the antibody-drug conjugate trastuzumab emtansine effectively prevents HER2-positive BC ...
Dr. Harsha Rajasimha discusses how Jeeva Clinical Trials aims to revolutionize global cancer research.
Carlos Doti, MD, of AstraZeneca, discusses the impact of LYNPARZA over the last decade.
Dr. Michal Sheleg discusses the benefit of MAIT cells compared with conventional T cells in treating solid tumors.
The FDA approved pembrolizumab with chemotherapy for adult patients with primary advanced, recurrent endometrial carcinoma.
Primary care providers are highly involved in opioid prescribing for HNC survivors.
Dr. Lopetegui-Lia reacts to Dr. Gatti-Mays' breast cancer panel discussion from Advancements in Oncology.
Dr. Margaret Gatti-Mays explains what makes The Oncology Brothers' content so important for community oncologists.
Dr. Margaret Gatti-Mays explains how to address the most pressing questions in triple-negative breast cancer treatments.
Dr. Gatti-Mays discusses how treatment for triple-negative breast cancer has evolved in recent years.
Dr. Margaret Gatti-Mays delves into the topic of HER2 tumor expression in breast cancer.
A study examined the impact of relationship satisfaction and agreement between breast cancer survivors and their partners.
Dr. Gatti-Mays talks about the importance of tailoring treatments to individual patients with breast cancer.
Scientists from Northwestern Medicine have made a huge step forward in the treatment glioblastoma.
Advertisement
630 Madison Ave.
Manalapan, NJ 07726
© 2024 Mashup Media, LLC. All rights reserved.